M&A Healthcare Advisors Brokers Innovo Detox Sale to R&S Holdings
MAHA facilitated the acquisition of Pennsylvania-based Innovo Detox, a substance use disorder treatment provider, by R&S Holdings, Inc.
M&A Healthcare Advisors (MAHA), a FINRA-licensed investment bank specializing in the healthcare sector, announced it advised on the sale of Innovo Detox to R&S Holdings, Inc., according to a statement released from Los Angeles.
Innovo Detox, headquartered in Pennsylvania, operates as a provider of substance use disorder treatment and drug rehabilitation services. The transaction adds a specialized behavioral health asset to R&S Holdings' portfolio, reflecting continued investor appetite for SUD treatment platforms amid ongoing demand for addiction care services nationwide.
Read more Small-Town Commercial Property Sales in Maine's Aroostook County Explained →
MAHA positions itself as a dedicated healthcare-focused advisory firm, navigating regulatory and valuation complexities particular to the behavioral health space. Deals of this nature typically involve FINRA oversight given the investment banking functions required in brokering healthcare business sales.
The transaction underscores a broader consolidation trend within the substance use disorder treatment sector, where regional providers are increasingly becoming acquisition targets for holding companies seeking to scale behavioral health operations. Pennsylvania has been among the states with significant infrastructure built around addiction treatment services.
Financial terms of the transaction were not disclosed in the announcement. Continue reading at All Financial Services & Investing.
